Skip to main content
. 2024 Dec 9;9:51. doi: 10.1186/s41256-024-00392-9

Table 3.

Factors associated with total costs (US$) incurred by the PwTB during TB care, India, 2022–2023 (N = 1398)

Characteristics n (%) Total cost median (IQR) Adjusted coefficients (95%CI) Marginal means (95% CI) p value
Overall 1398 (100) 392.7 (134.5, 878.0)
Age (in years)
 ≥ 18 to ≤ 59 1134 (81.1) 406.2 (145.3, 884.9) 108.55 (41.97, 175.13) 446.08 (370.37, 521.80) 0.001
 ≥ 60 264 (18.9) 261.6 (79.6, 838.8) Reference 337.54 (280.46, 394.61)
Gender
 Male 861 (61.6) 413.7 (160.0, 835.3) 36.00 (− 39.70, 111.71) 439.42 (354.14, 524.71) 0.351
 Female 537 (38.4) 354.8 (104.1, 906.4) Reference 403.42 (341.75, 465.09)
Education
 Illiterate 518 (37.1) 399.2 (133.7, 874.9)
 Any formal schooling 705 (50.4) 381.8 (133.2, 848.9)
 Any college education 175 (12.5) 396.7 (142.6, 926.2)
Occupationa
 Employed 785 (56.1) 425.7 (189.7, 778.4) Reference 449.77 (395.46, 504.07)
 Economically inactive 613 (43.9) 336.9 (84.8, 930.0) − 55.13 (− 179.21, 68.95) 394.64 (270.86, 518.42) 0.384
Monthly household income before TB (quintiles)
 1st (poorest) 259 (18.5) 347.3 (82.9, 899.8) − 81.72 (− 202.45, 39.01) 386.30 (286.37, 486.24) 0.184
 2nd 336 (24) 367.8 (133.0, 874.4) − 71.41 (− 169.02, 26.19) 396.61 (299.59, 493.63) 0.151
 3rd 254 (18.2) 427.8 (170.1, 815.7) − 30.11 (− 139.95, 79.73) 437.92 (341.67, 534.16) 0.591
 4th 277 (19.8) 395.8 (117.6, 800.2) − 22.84 (− 129.43, 83.75) 445.19 (349.77, 540.61) 0.674
 5th (richest) 268 (19.2) 480.6 (154.1, 974.7) Reference 468.03 (387.41, 548.64)
 Unknown/Missing 4 (0.3) 270.1 (162.2, 325.2)
Health/medical insurance scheme
 Yes 514 (36.8) 328.1 (101.3, 819.2) − 105.01 (− 206.75, − 3.27) 359.16 (265.89, 452.43) 0.043
 No 884 (63.2) 420.3 (155.9, 887.5) Reference 464.17 (386.73, 541.62)
Recipients of NPY
 Yes 1250 (89.4) 393.2 (134.5, 881.4)
 No 148 (10.6) 389.0 (117.2, 826.6)
Notifying sector
 Public 1263 (90.3) 367.1 (122.4, 841.7) Reference 398.68 (336.57, 460.78)
 Private 135 (9.7) 700.2 (255.6, 1097.3) 278.05 (− 66.69, 622.79) 676.72 (332.40, 1021.05) 0.114
Site of disease
 Extra Pulmonary 313 (22.4) 402.4 (142.6, 964.5)
 Pulmonary 1079 (77.2) 391.9 (130.8, 845.6)
 Unknown/Missing 6 (0.4) 278.6 (185.3, 701.2)
Drug typeb
 DSTB 1363 (97.5) 391.9 (133.7, 877.0)
 DRTB 34 (2.4) 495.8 (183.2, 911.2)
 Unknown/Missing 1 (0.1) 185.3 (185.3, 185.3)
HIV
 Reactive 15 (1.1) 529.2 (103.2, 1151.1)
 Non–Reactive 1358 (97.1) 393.2 (133.7, 878.0)
 Unknown/Missing 25 (1.8) 364.5 (185.3, 752.7)
Diabetes
 Diabetic 129 (9.2) 577.9 (195.1, 967.0) 57.51 (− 63.63, 178.66) 474.54 (360.58, 588.51) 0.352
 Non-Diabetic 1214 (86.8) 373.0 (125.5, 866.6) Reference 417.03 (344.55, 489.51)
 Unknown/Missing 55 (3.9) 428.8 (186.4, 752.7) 82.40 (− 58.04, 222.85) 499.44 (358.71, 640.17) 0.250
Hospitalization
 Yes 258 (18.5) 882.3 (408.0, 1554.1) 518.60 (379.09, 784.10) 900.39 (700.20, 1100.59) < 0.001
 No 1140 (81.5) 323.4 (101.5, 719.4) Reference 318.80 (254.58, 383.01)
Treatment outcome
 Favourable 1302 (93.1) 392.7 (134.1, 881.4)
 Unfavourable 96 (6.9) 386.7 (138.1, 759.6)

For marginal means, p value of 0.2 is considered for statistical significance

DSTB drug sensitive tuberculosis; DRTB drug resistant tuberculosis; HIV human immunodeficiency virus

aEmployed (Regular employee government/Regular employee private/Temporary employee (government and private)/Skilled worker/Daily wage earner/ Business/farm/shop); Economically inactive (Unemployed/Homemaker/Retired/Pensioner/Student)

bn is very low in the in unknown/missing category, so it was not considered for unadjusted analysis